Mystic Holdings, Inc. (OTCPK: MSTH)
Health Care · Pharmaceuticals · US
$—
— today · — 1Y
Mystic Holdings, Inc. (OTCPK: MSTH) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $124.91K and employs 130 people.
trading between 0.00 and 0.06.
Tweenvest scores Mystic Holdings, Inc. across four factors: quality 45/100, value 54/100, growth 99/100. Its strongest factor is growth.
MSTH price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $124.91K
- Revenue (TTM)
- $21.40M
- P/E
- —
- EPS
- -0.06
- Dividend yield
- —
- Beta (5Y)
- 0.16
- 52-week high
- $0.06
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 113.56M
- Employees
- 130
- Next earnings
- —
About Mystic Holdings, Inc.
Based in Las Vegas, Nevada, Mystic Holdings, Inc. functions as a comprehensive cannabis enterprise. Through its various subsidiaries, the company is involved in the cultivation, production, and wholesale distribution of both medical and recreational cannabis products across Nevada. Its diverse product line features raw cannabis flower, a wide array of edibles including gummies, brownie bites, cookies, caramels, rice crispies, and chocolate chip bars, alongside concentrates, oils, pre-rolled joints, small-batch buds, and cannabis vape offerings. These products are marketed under the Qualcan, Lush, and Cosmic brands. In addition to supplying state-licensed dispensaries, Mystic Holdings operates two of its own retail dispensaries catering to recreational and medical users and provides branding consultation for external cannabis products. The company was founded in 2014.
- Founded
- 2014
- Listed since
- Jul 19, 2022
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.